Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia.
Unresolved issues in dementia research include (1) the association between nonstroke cardiovascular disease (CVD) and Alzheimer disease (AD) and (2) whether the association between CVD and dementia is mediated by familial factors (ie, genes and early life environment). We therefore conducted a study with both a longitudinal and a co-twin control design in 2214 Swedish twins with clinical dementia evaluation and apolipoprotein E (ApoE) genotyping. The analyses were then replicated in a register-based cohort of 18,405 individuals. Results show that CVD increases the risk of AD in carriers (but not noncarriers) of the ApoE4 allele (hazard ratio 2.39, 95% confidence interval 1.15-4.96). CVD was also associated with an almost 2-fold increased risk of developing late-life dementia (hazard ratio 1.83, 95% confidence interval 1.23-2.72). Within twin pairs, the dementia-affected twin was more likely to have had CVD than the nondemented twin partner (odds ratio 1.86, 95% confidence interval 1.11-3.13). In conclusion, this study shows that (1) nonstroke CVD increases the risk of late-life dementia but that it is only a risk factor for AD in carriers of the ApoE4 allele and (2) the association between CVD and dementia is not explained by genetic or early life environmental factors in common to both disorders.
Eriksson
Ulrika K
UK
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Ulrika.Eriksson@ki.se
Bennet
Anna M
AM
Gatz
Margaret
M
Dickman
Paul W
PW
Pedersen
Nancy L
NL
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000453:epidemiology / Q000209:etiology* / Q000235:genetics; D053327:Apolipoprotein E4 / Q000235:genetics*; D002318:Cardiovascular Diseases / Q000150:complications* / Q000453:epidemiology / Q000235:genetics; D015331:Cohort Studies; D004777:Environment; D005260:Female; D005838:Genotype; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D012042:Registries; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology; D014427:Twins / Q000235:genetics*
D053327:Apolipoprotein E4
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
JAMA. 1997 Oct 22-29;278(16):1349-56
9343467
J Intern Med. 2006 Sep;260(3):211-23
16918818
Lancet Neurol. 2007 Aug;6(8):734-46
17616482
Neurology. 2000 Jan 25;54(2):397-402
10668701
Lancet. 2004 Apr 3;363(9415):1139-46
15064035
J Gerontol A Biol Sci Med Sci. 1997 Mar;52(2):M117-25
9060980
Neurology. 1993 Feb;43(2):250-60
8094895
Neurology. 1984 Jul;34(7):939-44
6610841
Neurology. 1999 Oct 22;53(7):1593-5
10534277
Ann Neurol. 2006 Dec;60(6):677-87
17192928
J Am Geriatr Soc. 2005 Jul;53(7):1101-7
16108925
Lancet. 1997 Jan 18;349(9046):151-4
9111537
Arch Intern Med. 2005 Feb 14;165(3):321-6
15710796
Lancet Neurol. 2005 Nov;4(11):752-9
16239182
Ann Neurol. 2007 May;61(5):403-10
17328068
J Intern Med. 2002 Sep;252(3):184-205
12270000
Behav Genet. 2003 Mar;33(2):95-105
14574145
Dement Geriatr Cogn Disord. 2008;25(2):148-56
18097143
JAMA. 2007 Sep 19;298(11):1300-11
17878422
BMJ. 1994 Jun 18;308(6944):1604-8
8025427
Neurology. 2004 Apr 13;62(7):1148-55
15079015
Circulation. 2009 Jan 27;119(3):e21-181
19075105
Nature. 2000 Sep 14;407(6801):233-41
11001066
Dement Geriatr Cogn Disord. 2006;22(3):244-9
16902279
Arch Intern Med. 2006 May 8;166(9):1003-8
16682574
Alzheimer Dis Assoc Disord. 2002 Oct-Dec;16(4):203-12
12468894
Science. 1997 Jun 6;276(5318):1560-3
9171059
J Gerontol B Psychol Sci Soc Sci. 2002 May;57(3):S168-76
11983743
Neurology. 2006 May 9;66(9):1399-404
16682673
Aging Clin Exp Res. 2007 Oct;19(5):381-9
18007116
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5644-51
16567625
Lancet. 2001 Jan 20;357(9251):169-75
11213093
Neurology. 2004 Aug 24;63(4):739-41
15326258